Suppr超能文献

新辅助治疗后机器人手术与腹腔镜手术治疗局部进展期胃癌的短期和长期疗效比较:一项高容量中心倾向评分匹配的回顾性研究

Comparison of short- and long-term outcomes of robotic versus laparoscopic gastrectomy for locally advanced gastric cancer after neoadjuvant therapy: a high-volume center retrospective study with propensity score matching.

作者信息

Liu Qi, Meng Cheng, Cao Shougen, Liu Xiaodong, Tian Yulong, Li Zequn, Zhong Hao, Sun Yuqi, Yu Junjian, Zhou Yanbing

机构信息

Department of General Surgery, Affiliated Hospital of Qingdao University, 16# Jiangsu Road, Qingdao, 266000, Shandong Province, People's Republic of China.

Gastrointestinal Tumor Translational Medicine Research Institute of Qingdao University, Qingdao, Shandong Province, China.

出版信息

Surg Endosc. 2025 May;39(5):2814-2827. doi: 10.1007/s00464-025-11626-3. Epub 2025 Mar 10.

Abstract

BACKGROUND

Although neoadjuvant therapy (NAT) for advanced gastric cancer (AGC) can benefit patient survival, few studies have compared the short- and long-term outcomes of robotic and laparoscopic gastrectomy for AGC after NAT.

METHODS

The clinical data of 321 AGC patients who received NATs and who underwent robotic gastrectomy (RG, n = 109) or laparoscopic gastrectomy (LG, n = 212) between May 2017 and September 2022 were collected and analyzed retrospectively at our center. After propensity score matching (PSM) for 1:1 matching to eliminate bias, both groups had 106 cases. Short-term clinical outcomes and long-term survival-related indicators were compared between the two groups of patients.

RESULTS

A total of 212 patients were included in the groups after matching. There were fewer overall complications (13.2% vs. 28.3%, P = 0.007) and surgical complications (8.5% vs. 17.9%, P = 0.043) in the RG group than in the LG group. Compared with the LG group, the RG group had more harvested overall lymph nodes (35.25 ± 4.99 vs. 31.45 ± 6.31, P < 0.001) and more suprapancreatic lymph nodes (13.12 ± 4.38 vs. 10.05 ± 4.13, P < 0.001). Patients in the RG group had significantly shorter surgery times (217.62 ± 47.49 vs. 267.25 ± 70.68, P < 0.001) and less blood loss (46.51 ± 27.02 vs. 70.75 ± 37.25, P < 0.001) than patients in the LG group. The RG group had significantly faster bowel function recovery, earlier liquid diet, and shorter hospital stay. Compared with LG, RG had a better 3-year RFS (75.5% vs. 62.3%, P = 0.017).

CONCLUSION

Compared with laparoscopic surgery, robotic surgery significantly increased the number of lymph node dissected, reduced intraoperative blood loss, and postoperative surgical complications rate. Although RG did not statistically improve 3-year overall survival, there was a significant improvement in RFS and could be an alternative surgical method for GC patients after NAC.

摘要

背景

尽管晚期胃癌(AGC)的新辅助治疗(NAT)可使患者生存获益,但很少有研究比较NAT后AGC的机器人辅助与腹腔镜胃切除术的短期和长期结局。

方法

回顾性收集并分析了2017年5月至2022年9月期间在本中心接受NAT且接受机器人辅助胃切除术(RG,n = 109)或腹腔镜胃切除术(LG,n = 212)的321例AGC患者的临床资料。在进行倾向评分匹配(PSM)以1:1匹配以消除偏差后,两组各有106例病例。比较两组患者的短期临床结局和长期生存相关指标。

结果

匹配后两组共纳入212例患者。RG组的总体并发症(13.2%对28.3%,P = 0.007)和手术并发症(8.5%对17.9%,P = 0.043)少于LG组。与LG组相比,RG组切除的总淋巴结更多(35.25±4.99对31.45±6.31,P < 0.001),胰上淋巴结更多(13.12±4.38对10.05±4.13,P < 0.001)。RG组患者的手术时间明显短于LG组(217.62±47.49对267.25±70.68,P < 0.001),失血量也更少(46.51±27.02对70.75±37.25,P < 0.001)。RG组的肠功能恢复明显更快,流质饮食更早,住院时间更短。与LG相比,RG的3年无复发生存率更好(75.5%对62.3%,P = 0.017)。

结论

与腹腔镜手术相比,机器人手术显著增加了淋巴结清扫数量,减少了术中失血量和术后手术并发症发生率。尽管RG在统计学上未改善3年总生存率,但无复发生存率有显著改善,可作为NAC后GC患者的替代手术方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验